Stay updated with breaking news from Quick Inventory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Single-dose synthetic psilocybin improves the core symptoms of treatment-resistant depression, while other frequently measured parameters only contribute 'noise' to the outcome, phase 2 data show.
ECT in older patients with refractory depression and bipolar disorder has been linked to cognitive improvement, allaying fears that the treatment could have a deleterious impact in this patient population.
Repeated IV ketamine infusions were associated with improved psychosocial functional impairments in adults with treatment-resistant bipolar disorder.
Approximately one-third of patients with MDD benefitted substantially from treatment with an acute induction course of ketamine infusions.
Bilateral TBS achieved noninferior symptom reduction compared with standard bilateral rTMS in older adults with treatment-resistant depression.